Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas

NCT01502605 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
6
Enrollment
OTHER
Sponsor class

Stopped PI leaving institution

Conditions

Interventions

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins